Is FDA Approval in the Bag for NPS? (NPSP)

Is FDA Approval in the Bag for NPS?

Before today's Food and Drug Administration advisory committee voted unanimously, 12-0, in favor of NPS Pharmaceuticals, health care analysts David Williamson and Max Macaluso discussed the likelihood of FDA approval for its lead drug, Gattex. Although getting a positive vote out of the advisory committee it is just a step in overall approval, today is an important day for NPS and its shareholders.

Many investors are attracted to NPS and biotechs like it since they hold the allure of substantial short-term gains. But there is more than one approach to building long-term wealth and retiring well. In our free report "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you as well as some winning wealth-building strategies. Click here to keep reading.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Dave Williamson has no positions in the stocks mentioned above. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

updated 18 hours ago Sponsored by:
	DOW	15,303.10	8.60	0.06%
	S&P 500	1,649.60	-0.91	-0.06%
	NASD	3,459.14	-0.28	-0.01%

NPSP	$14.91		-0.34	-2.23%
NPS Pharmaceutical…		CAPS Rating:

My Watchlist

2

Is FDA Approval in the Bag for NPS?

Comments from our Foolish Readers

Be the first one to comment on this article.

Compare Brokers

Report This Comment

Sending report...

Today's Market

Create My Watchlist

You don't seem to be following any stocks yet!

Related Tickers